La Telecobaltoterapia Come Unico Trattamento Delle Neoplasie Laringee

Abstract

194 laryngeal tumors were treated with cobalt teletherapy. They were classified according to the T.N.M. system and 168 have been evaluated statistically (T1 – T2 = 42; T3 – T4 = 124). The results are shown in a series of survival curves; the five-year survival rate is 21.6 %. This experience confirms the value of radiotherapy as a useful conservative treatment, although in many extensive cases (T3 – T4) radiotherapy ensures longer survival if combined with surgery.